Supplemental figure 1

1
Supplemental figure 1 The proportion of n-alkanes extracted from the wing and Dufour’s gland samples for each species of bumblebee. The top two graphs are for the non-parasitic Bombus species, while the bottom two inverted graphs shows the data for the corresponding Psithyrus-cuckoo species. The arrows indicate alternative hosts. The error bars represent one SD. Proportion of each alkane B.(Ps.) vestalis B.(Ps.) campestris B.(Ps.) sylvestris B.(Ps.) rupestris B.(Ps.) bohemicus F B.(Ps.) bohemicus UK 0 10 20 30 40 50 60 70 C 21 C 23 C 25 C 27 C 29 C 31 0 10 20 30 40 50 60 70 B. terrestris type II B. pascuorum B. hortorum B. lapidarius B. jonellus B. pratorum B. lucorum F B. terrestris B. lucorum UK B. muscorum B. monticola 30 10 20 40 0 30 10 20 40 Wing Wing Dufour’s gland Dufour’s gland

description

Wing. 40. 30. 20. 10. 70. Dufour’s gland. 60. 50. 40. 30. 20. 10. 0. B. lucorum F. B. terrestris. B. terrestris type II. B. pascuorum. B. lucorum UK. B. hortorum. Proportion of each alkane. B. pratorum. B. jonellus. B. lapidarius. B. monticola. B. muscorum. - PowerPoint PPT Presentation

Transcript of Supplemental figure 1

Page 1: Supplemental figure 1

Supplemental figure 1The proportion of n-alkanes extracted from the wing and Dufour’s gland samples for each species of bumblebee. The top two graphs are for the non-parasitic Bombus species, while the bottom two inverted graphs shows the data for the corresponding Psithyrus-cuckoo species. The arrows indicate alternative hosts. The error bars represent one SD.

Pro

port

ion

of e

ach

alka

ne

B.(Ps.) vestalisB.(Ps.) campestris B.(Ps.) sylvestris B.(Ps.) rupestrisB.(Ps.) bohemicus

FB.(Ps.) bohemicus

UK0

10

20

30

40

50

60

70

C21

C23

C25

C27

C29

C31

0

10

20

30

40

50

60

70

B. terrestris type II

B. pascuorum B. hortorumB. lapidarius B. jonellusB. pratorum B. lucorum F

B. terrestris B. lucorum UK

B. muscorum B. monticola

30

10

20

40

0

30

10

20

40

Wing

Wing

Dufour’s gland

Dufour’s gland

Supplemental Figure 1 - Genes & Developmentgenesdev.cshlp.org/content/suppl/2013/11/01/27.21... · Supplemental Figure 1 Supplemental Fig. 1. (A) The binding avidity between Fz4-FcH6

Supplemental Figure 1 - Genes & Developmentgenesdev.cshlp.org/content/suppl/2013/11/01/27.21... · Supplemental Figure 1 Supplemental Fig. 1. (A) The binding avidity between Fz4-FcH6

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

Supplemental Figure Legend Supplemental Figure 1 A · Supplemental Figure Legend Supplemental Figure 1 (A) Principal component analysis of gene expression of Panc-1 and BxPC3 cells.All

Supplemental Figure Legend Supplemental Figure 1 A · Supplemental Figure Legend Supplemental Figure 1 (A) Principal component analysis of gene expression of Panc-1 and BxPC3 cells.All

Supplemental Figure 1.

Supplemental Figure 1.

Supplemental Figures Supplemental Figure 1€¦ · Supplemental Figures . Supplemental Figure 1 . Supplemental Figure 1. AdipoChaser mouse models used for cold and thermoneutral exposures.

Supplemental Figures Supplemental Figure 1€¦ · Supplemental Figures . Supplemental Figure 1 . Supplemental Figure 1. AdipoChaser mouse models used for cold and thermoneutral exposures.

BolteusBordey Supplemental Figure 1

BolteusBordey Supplemental Figure 1

List of Supplemental Digital Content Supplemental Figure 1 ...

List of Supplemental Digital Content Supplemental Figure 1 ...

Supplemental Figure 1

Supplemental Figure 1

Collected Supplemental Figures Marginsgenesdev.cshlp.org/content/suppl/2007/10/01/21.19.2448.DC1/... · Supplemental Figure 2 Supplemental Figure 4 Supplemental Figure 5 Supplemental

Collected Supplemental Figures Marginsgenesdev.cshlp.org/content/suppl/2007/10/01/21.19.2448.DC1/... · Supplemental Figure 2 Supplemental Figure 4 Supplemental Figure 5 Supplemental

Supplemental Tables and Supplemental Figure Legends...2014/04/14  · 1 Supplemental Tables and Supplemental Figure Legends 2 3 Supplementary Figure Legends 4 5 Figure S1. SDS-PAGE

Supplemental Tables and Supplemental Figure Legends...2014/04/14  · 1 Supplemental Tables and Supplemental Figure Legends 2 3 Supplementary Figure Legends 4 5 Figure S1. SDS-PAGE

Supplemental Figure Legends: Supplemental Figure S1 ...genesdev.cshlp.org/content/suppl/2014/07/11/gad... · Supplemental Figure Legends: Supplemental Figure S1 Vernalization response

Supplemental Figure Legends: Supplemental Figure S1 ...genesdev.cshlp.org/content/suppl/2014/07/11/gad... · Supplemental Figure Legends: Supplemental Figure S1 Vernalization response

Supplemental data: Supplemental Figure 1. Sequence of ...

Supplemental data: Supplemental Figure 1. Sequence of ...

Figure legends: Supplemental Figure 1 A) TAA;

Figure legends: Supplemental Figure 1 A) TAA;

SUPPLEMENTAL FIGURE LEGENDS Supplemental Fig… · SUPPLEMENTAL FIGURE LEGENDS Supplemental Fig. 1. ... Schematic representation of zebrafish ATX gene with exons ... LPA 1 MO caused

SUPPLEMENTAL FIGURE LEGENDS Supplemental Fig… · SUPPLEMENTAL FIGURE LEGENDS Supplemental Fig. 1. ... Schematic representation of zebrafish ATX gene with exons ... LPA 1 MO caused

Supplemental figure 1: Dapul_304363

Supplemental figure 1: Dapul_304363

Supplemental Figure 1

Supplemental Figure 1

Supplemental Figure 1 - Journal of CancerSupplemental Figure 2 . Supplemental Figure 3 . Supplemental Table 1. Relationship between CD4 TIL expression and various patient characteristics

Supplemental Figure 1 - Journal of CancerSupplemental Figure 2 . Supplemental Figure 3 . Supplemental Table 1. Relationship between CD4 TIL expression and various patient characteristics

Supplemental Figure Legend Supplemental Figure 1 ... · Supplemental Figure 4. Recombinant factors needed to be applied in cocktail form to achieve nuclear translocation. Nuclear

Supplemental Figure Legend Supplemental Figure 1 ... · Supplemental Figure 4. Recombinant factors needed to be applied in cocktail form to achieve nuclear translocation. Nuclear

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

Supplemental Material Supplemental Figure 1. Further Analysis of … · 2013-04-17 · ! 1! Supplemental Material Supplemental Figure 1. Further Analysis of CX3CR1 Expressing Myeloid

Supplemental Material Supplemental Figure 1. Further Analysis of … · 2013-04-17 · ! 1! Supplemental Material Supplemental Figure 1. Further Analysis of CX3CR1 Expressing Myeloid